Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 Sep 15;102(6):1265–1273. doi: 10.1172/JCI3022

MHC haplotype-dependent regulation of MOG-induced EAE in rats.

R Weissert 1, E Wallström 1, M K Storch 1, A Stefferl 1, J Lorentzen 1, H Lassmann 1, C Linington 1, T Olsson 1
PMCID: PMC509110  PMID: 9739061

Abstract

Experimental autoimmune encephalomyelitis (EAE) induced in the rat by active immunization with myelin-oligodendrocyte-glycoprotein (MOG) is mediated by synergy between MOG-specific T cells and demyelinating MOG-specific antibody responses. The resulting disease is chronic and displays demyelinating central nervous system (CNS) pathology that closely resembles multiple sclerosis. We analyzed major histocompatibility complex (MHC) haplotype influences on this disease. The MHC haplotype does not exert an all-or-none effect on disease susceptibility. Rather, it determines the degree of disease susceptibility, recruitment of MOG-specific immunocompetent cells, clinical course, and CNS pathology in a hierarchical and allele-specific manner. Major haplotype-specific effects on MOG-EAE map to the MHC class II gene region, but this effect is modified by other MHC genes. In addition, non-MHC genes directly influence both disease and T cell functions, such as the secretion of IFN-gamma. Thus, in MOG-EAE, allelic MHC class II effects are graded, strongly modified by other MHC genes, and overcome by effects of non-MHC genes and environment.

Full Text

The Full Text of this article is available as a PDF (359.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adelmann M., Wood J., Benzel I., Fiori P., Lassmann H., Matthieu J. M., Gardinier M. V., Dornmair K., Linington C. The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat. J Neuroimmunol. 1995 Dec;63(1):17–27. doi: 10.1016/0165-5728(95)00124-7. [DOI] [PubMed] [Google Scholar]
  2. Amor S., Groome N., Linington C., Morris M. M., Dornmair K., Gardinier M. V., Matthieu J. M., Baker D. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J Immunol. 1994 Nov 15;153(10):4349–4356. [PubMed] [Google Scholar]
  3. Baron J. L., Madri J. A., Ruddle N. H., Hashim G., Janeway C. A., Jr Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J Exp Med. 1993 Jan 1;177(1):57–68. doi: 10.1084/jem.177.1.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Berger T., Weerth S., Kojima K., Linington C., Wekerle H., Lassmann H. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system. Lab Invest. 1997 Mar;76(3):355–364. [PubMed] [Google Scholar]
  5. Blackman M. A., Marrack P., Kappler J. Influence of the major histocompatibility complex on positive thymic selection of V beta 17a+ T cells. Science. 1989 Apr 14;244(4901):214–217. doi: 10.1126/science.2784868. [DOI] [PubMed] [Google Scholar]
  6. Genain C. P., Nguyen M. H., Letvin N. L., Pearl R., Davis R. L., Adelman M., Lees M. B., Linington C., Hauser S. L. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J Clin Invest. 1995 Dec;96(6):2966–2974. doi: 10.1172/JCI118368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gorham J. D., Güler M. L., Steen R. G., Mackey A. J., Daly M. J., Frederick K., Dietrich W. F., Murphy K. M. Genetic mapping of a murine locus controlling development of T helper 1/T helper 2 type responses. Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12467–12472. doi: 10.1073/pnas.93.22.12467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hammer J., Gallazzi F., Bono E., Karr R. W., Guenot J., Valsasnini P., Nagy Z. A., Sinigaglia F. Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J Exp Med. 1995 May 1;181(5):1847–1855. doi: 10.1084/jem.181.5.1847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Happ M. P., Wettstein P., Dietzschold B., Heber-Katz E. Genetic control of the development of experimental allergic encephalomyelitis in rats. Separation of MHC and non-MHC gene effects. J Immunol. 1988 Sep 1;141(5):1489–1494. [PubMed] [Google Scholar]
  10. Johns T. G., Kerlero de Rosbo N., Menon K. K., Abo S., Gonzales M. F., Bernard C. C. Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. J Immunol. 1995 May 15;154(10):5536–5541. [PubMed] [Google Scholar]
  11. Jones B., Janeway C. A., Jr Cooperative interaction of B lymphocytes with antigen-specific helper T lymphocytes is MHC restricted. Nature. 1981 Aug 6;292(5823):547–549. doi: 10.1038/292547a0. [DOI] [PubMed] [Google Scholar]
  12. Kojima K., Berger T., Lassmann H., Hinze-Selch D., Zhang Y., Gehrmann J., Reske K., Wekerle H., Linington C. Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia. J Exp Med. 1994 Sep 1;180(3):817–829. doi: 10.1084/jem.180.3.817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kropshofer H., Hämmerling G. J., Vogt A. B. How HLA-DM edits the MHC class II peptide repertoire: survival of the fittest? Immunol Today. 1997 Feb;18(2):77–82. doi: 10.1016/s0167-5699(97)01006-2. [DOI] [PubMed] [Google Scholar]
  14. Lanzavecchia A. Antigen-specific interaction between T and B cells. Nature. 1985 Apr 11;314(6011):537–539. doi: 10.1038/314537a0. [DOI] [PubMed] [Google Scholar]
  15. Lanzavecchia A. Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes. Annu Rev Immunol. 1990;8:773–793. doi: 10.1146/annurev.iy.08.040190.004013. [DOI] [PubMed] [Google Scholar]
  16. Lassmann H., Brunner C., Bradl M., Linington C. Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions. Acta Neuropathol. 1988;75(6):566–576. doi: 10.1007/BF00686201. [DOI] [PubMed] [Google Scholar]
  17. Levine S., Sowinski R. Allergic encephalomyelitis in the reputedly resistant Brown Norway strain of rats. J Immunol. 1975 Feb;114(2 Pt 1):597–601. [PubMed] [Google Scholar]
  18. Linington C., Bradl M., Lassmann H., Brunner C., Vass K. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol. 1988 Mar;130(3):443–454. [PMC free article] [PubMed] [Google Scholar]
  19. Lorentzen J. C., Issazadeh S., Storch M., Mustafa M. I., Lassman H., Linington C., Klareskog L., Olsson T. Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngeneic spinal cord and incomplete Freund's adjuvant. J Neuroimmunol. 1995 Dec 31;63(2):193–205. doi: 10.1016/0165-5728(95)00153-0. [DOI] [PubMed] [Google Scholar]
  20. Lucchinetti C. F., Brück W., Rodriguez M., Lassmann H. Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Brain Pathol. 1996 Jul;6(3):259–274. doi: 10.1111/j.1750-3639.1996.tb00854.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Mustafa M., Vingsbo C., Olsson T., Issazadeh S., Ljungdahl A., Holmdahl R. Protective influences on experimental autoimmune encephalomyelitis by MHC class I and class II alleles. J Immunol. 1994 Oct 1;153(7):3337–3344. [PubMed] [Google Scholar]
  22. Nakano N., Rooke R., Benoist C., Mathis D. Positive selection of T cells induced by viral delivery of neopeptides to the thymus. Science. 1997 Jan 31;275(5300):678–683. doi: 10.1126/science.275.5300.678. [DOI] [PubMed] [Google Scholar]
  23. Olerup O., Hillert J. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens. 1991 Jul;38(1):1–15. doi: 10.1111/j.1399-0039.1991.tb02029.x. [DOI] [PubMed] [Google Scholar]
  24. Parker D. C. T cell-dependent B cell activation. Annu Rev Immunol. 1993;11:331–360. doi: 10.1146/annurev.iy.11.040193.001555. [DOI] [PubMed] [Google Scholar]
  25. Pfeiffer C., Stein J., Southwood S., Ketelaar H., Sette A., Bottomly K. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J Exp Med. 1995 Apr 1;181(4):1569–1574. doi: 10.1084/jem.181.4.1569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Piddlesden S. J., Storch M. K., Hibbs M., Freeman A. M., Lassmann H., Morgan B. P. Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis. J Immunol. 1994 Jun 1;152(11):5477–5484. [PubMed] [Google Scholar]
  27. Powis S. J., Young L. L., Joly E., Barker P. J., Richardson L., Brandt R. P., Melief C. J., Howard J. C., Butcher G. W. The rat cim effect: TAP allele-dependent changes in a class I MHC anchor motif and evidence against C-terminal trimming of peptides in the ER. Immunity. 1996 Feb;4(2):159–165. doi: 10.1016/s1074-7613(00)80680-9. [DOI] [PubMed] [Google Scholar]
  28. Schmidt D., Verdaguer J., Averill N., Santamaria P. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity. J Exp Med. 1997 Oct 6;186(7):1059–1075. doi: 10.1084/jem.186.7.1059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Sebzda E., Wallace V. A., Mayer J., Yeung R. S., Mak T. W., Ohashi P. S. Positive and negative thymocyte selection induced by different concentrations of a single peptide. Science. 1994 Mar 18;263(5153):1615–1618. doi: 10.1126/science.8128249. [DOI] [PubMed] [Google Scholar]
  30. Segal B. M., Shevach E. M. IL-12 unmasks latent autoimmune disease in resistant mice. J Exp Med. 1996 Aug 1;184(2):771–775. doi: 10.1084/jem.184.2.771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Steinman L. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell. 1996 May 3;85(3):299–302. doi: 10.1016/s0092-8674(00)81107-1. [DOI] [PubMed] [Google Scholar]
  32. Stepaniak J. A., Gould K. E., Sun D., Swanborg R. H. A comparative study of experimental autoimmune encephalomyelitis in Lewis and DA rats. J Immunol. 1995 Sep 1;155(5):2762–2769. [PubMed] [Google Scholar]
  33. Sundvall M., Jirholt J., Yang H. T., Jansson L., Engström A., Pettersson U., Holmdahl R. Identification of murine loci associated with susceptibility to chronic experimental autoimmune encephalomyelitis. Nat Genet. 1995 Jul;10(3):313–317. doi: 10.1038/ng0795-313. [DOI] [PubMed] [Google Scholar]
  34. Tisch R., McDevitt H. Insulin-dependent diabetes mellitus. Cell. 1996 May 3;85(3):291–297. doi: 10.1016/s0092-8674(00)81106-x. [DOI] [PubMed] [Google Scholar]
  35. Vass K., Lassmann H., Wekerle H., Wisniewski H. M. The distribution of Ia antigen in the lesions of rat acute experimental allergic encephalomyelitis. Acta Neuropathol. 1986;70(2):149–160. doi: 10.1007/BF00691433. [DOI] [PubMed] [Google Scholar]
  36. Vyse T. J., Todd J. A. Genetic analysis of autoimmune disease. Cell. 1996 May 3;85(3):311–318. doi: 10.1016/s0092-8674(00)81110-1. [DOI] [PubMed] [Google Scholar]
  37. Wedekind D., Prokop C. M., Brunsberg U., Holmdahl R., Hedrich H. J. Identification and differentiation of transcribed major histocompatibility complex class II RT1B alpha and RT1B beta alleles from laboratory rats. Transplant Proc. 1997 May;29(3):1668–1669. doi: 10.1016/s0041-1345(97)00008-0. [DOI] [PubMed] [Google Scholar]
  38. Yamamura T., Namikawa T., Endoh M., Kunishita T., Tabira T. Experimental allergic encephalomyelitis induced by proteolipid apoprotein in Lewis rats. J Neuroimmunol. 1986 Aug;12(2):143–153. doi: 10.1016/0165-5728(86)90027-5. [DOI] [PubMed] [Google Scholar]
  39. Zachau A. C., Strigård K., Baig S., Höjeberg B., Olsson T. Distribution of plasma cells secreting antibodies against nervous tissue antigens during experimental allergic encephalomyelitis enumerated by a nitrocellulose immunospot assay. J Neurol Sci. 1989 Jul;91(3):323–336. doi: 10.1016/0022-510x(89)90061-0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES